Zafemy 150-35 MCG/day patch 3S
Ended Awarded
- Contract number
- SPE2DB26FAUAR
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,407
Award facts
- Contract value 100% obligated
- $4,406.97 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $4,406.97 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for ZAFEMY 150-35 MCG/DAY patches (a quantity of 3 units). This firm fixed-price delivery order was awarded on October 30, 2025, with an ultimate completion date of October 31, 2025, and will be performed in Conshohocken, Pennsylvania. The award includes no set-aside designation, demonstrating DMS Pharmaceutical Group's competitive capability in unrestricted federal procurement. The delivery order is issued under the company's broader Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) Indefinite Delivery Contract with the Defense Logistics Agency, a $30.3 billion government-wide acquisition vehicle designed to supply diverse pharmaceutical products and medical consumables to Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group Inc. serves as a critical pharmaceutical supplier within the federal military medical supply chain, with its PPV-G GEN V prime vendor contract featuring a ceiling value of $499,999,999 and completion through December 31, 2036. The company's product portfolio encompasses branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables across multiple therapeutic categories. Through its established performance on numerous Defense Logistics Agency delivery orders, DMS Pharmaceutical Group has demonstrated consistent capability to fulfill the specialized pharmaceutical requirements supporting military healthcare operations globally.
Quick answers
Who was awarded contract SPE2DB26FAUAR?
SPE2DB26FAUAR was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 30, 2025.
How much is contract SPE2DB26FAUAR worth?
The government has obligated $4,407 on SPE2DB26FAUAR.
Is contract SPE2DB26FAUAR an order under another contract?
Yes. SPE2DB26FAUAR is a delivery order under SPE2DB24D2106, an indefinite delivery contract.
Was contract SPE2DB26FAUAR competed?
The extent of competition for SPE2DB26FAUAR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award